A growing interest has been recently devoted to the role of intracellular Ca 2+ storage organelles in neuroprotection induced by ischemic preconditioning (IPC) 1, 2 -a brief nonlethal ischemic episode that affords tolerance to a subsequent ischemic insult. [3] [4] [5] Disturbance of Ca 2+ homeostasis in the endoplasmic reticulum (ER) represents a common denominator of neuronal cell injury in many neurological disorders, including stroke. 6 Restoring ER Ca 2+ homeostasis could be a new potential strategy in neurodegeneration. Accordingly, the NCX (Na + /Ca 2+ exchanger), 7, 8 the Na + /H + exchanger 1, 9 the calcium-binding protein calretinin, 10, 11 and the ER chaperone protein GRP78 12 have all been recently identified as molecular mediators of ischemic tolerance in neurons. For instance, severe deficiencies in ER Ca 2+ refilling and NCX activity under hypoxic conditions in neurons 13, 14 can lead to neuronal death. By contrast, increases in NCX reverse mode of operation contribute to IPC-induced Ca 2+ refilling into the ER, thereby promoting neuroprotection. 8 Besides Ca 2+ storage, the ER has an essential function in the Ca 2+ -dependent folding of newly synthesized proteins. 15, 16 Background and Purpose-Disturbance of endoplasmic reticulum (ER) Ca 2+ homeostasis causes neuronal cell injury in stroke. By contrast, ischemic preconditioning (IPC)-a brief sublethal ischemic episode affording tolerance to a subsequent ischemic insult-restores ER Ca 2+ homeostasis. Under physiological conditions, ER calcium content is continuously refilled by the interaction between the ER-located Ca 2+ sensor STIM (stromal interacting molecule) 1 and the plasma membrane channel ORAI1 (a structural component of the CRAC calcium channel)-2 key mediators of the store-operated calcium entry (SOCE) mechanism. However, the role played by ORAI1 and STIM1 in stroke and in IPCinduced neuroprotection during stroke remains unknown. Therefore, we explored whether ORAI1 and STIM1 might be involved in stroke pathogenesis and in IPC-induced neuroprotection. Methods-Primary cortical neurons were subjected to oxygen and glucose deprivation+reoxygenation to reproduce in vitro brain ischemia. Focal brain ischemia and IPC were induced in rats by transient middle cerebral artery occlusion. Expression of ORAI1 and STIM1 transcripts and proteins and their immunosignals were detected by qRT-PCR, Western blot, and immunocytochemistry, respectively. SOCE and Ca 2+ release-activated Ca 2+ currents (I CRAC ) were measured by Fura-2 AM video imaging and patch-clamp electrophysiology in whole-cell configuration, respectively. Results-STIM1 and ORAI1 protein expression and immunosignals decreased in the ipsilesional temporoparietal cortex of rats subjected to transient middle cerebral artery occlusion followed by reperfusion. 17 and some transcription factors 18, 19 that, in turn, activate the defensive mechanism called unfolded protein response. 6 Prolonged activation of unfolded protein response results in cell death via ER stress. 6 Therefore, severe Ca 2+ depletion from the ER may account for cell death.
14 Under physiological conditions, ER Ca 2+ content is continuously refilled by the interaction between the ER-located Ca 2+ sensor STIM (stromal interacting molecule) 1 and the plasma membrane channel ORAI1. 20 Cooperating with other partners, 21 these 2 proteins mediate the mechanism called store-operated calcium entry (SOCE), which controls different cell functions. [22] [23] [24] [25] [26] [27] [28] [29] On ER Ca 2+ depletion, STIM1 translocates to the plasma membrane and forms highly Ca 2+ selective pores with the plasma membrane ORAI1. 30, 31 This leads to the Ca 2+ influx from the extracellular space directly into ER [32] [33] [34] through the Ca 2+ release-activated Ca 2+ current (I CRAC ). Although well characterized under physiological conditions, the role played by ORAI1 and STIM1 in stroke and in IPC-induced neuroprotection remains completely unknown. In this study, we tested (1) whether hypoxic conditions in primary cortical neurons or transient middle cerebral artery occlusion (tMCAO) might modulate protein expression, interaction, and activity between ORAI1 and STIM1 and (2) whether ORAI1 and STIM1 might be involved in IPC-induced neuroprotection.
Methods

Data, Materials, and Code Disclosure Statement
The data that support the findings of this study are available from the corresponding authors on reasonable request.
Primary Cortical Neurons and siRNA Treatments
Cortical neurons were obtained from brains of 14/16-day-old Wistar rat embryos and dissected as reported previously. 8 After 5/6 days in vitro cortical neurons were transfected with specific siRNAs (#1 or #2) against ORAI1 or STIM1 (Qiagen, Mi, Italy) in order to knock down these proteins. Only siRNAs #2 efficiently reduced ORAI1 or STIM1 protein expression. All animal procedures were performed in accordance with the Animal Care Committee of Federico II University of Naples by Italian Ministerial Authorization (DL 116/92 art.7).
Combined Oxygen and Glucose Deprivation
Preconditioning insult and hypoxia were reproduced in vitro as reported previously. 8 
[Ca
2+
] i Measurements [Ca 2+ ] i was measured by single-cell computer-assisted video imaging as reported previously. 13, 14 For SOCE analysis, neurons were exposed to thapsigargin in the absence of extracellular calcium and, then, reexposed to 2 mmol/L Ca 2+ . Nimodipine and ω-conotoxin were added during the recording. -independent currents. The 2-APB-insensitive components were subtracted from total currents to isolate I CRAC . Capacitive currents were estimated from the decay of capacitive transients induced by 5 mV depolarizing pulses from a holding potential of −80 mV and acquired at a sampling rate of 50 kHz. Furthermore, I CRAC was normalized to membrane capacitance to exclude possible changes in cell size caused by specific treatments (measured as pA/pF).
Determination of Cell Death
Cell death was measured as reported previously.
13
Transient Focal Ischemia and IPC
Fifty-seven Sprague Dawley male rats (200-225 g; Charles River, Italy), housed under diurnal lighting conditions (12-hour darkness/ light), were used. Experiments were performed in a blinded manner. Animal handling was done in accordance with the international guidelines for animal research (ARRIVE). Transient focal ischemia was induced by suture occlusion of middle cerebral artery in male rats anesthetized with a mixture of 2% sevoflurane and 98% O 2 (Oxygen Concentrator Mod. LFY-I-5). 7 Achievement of ischemia was confirmed by monitoring regional cerebral blood flow. Animals not showing cerebral blood flow reduction of at least 70% (n=9), as well as those dying after ischemia induction (n=6), were excluded from the study. For the experiments, rats were divided into 6 experimental groups: (1) sham-operated rats, (2) ischemic rats (tMCAO+vehicle), (3) preconditioned rats (IPC+vehicle), (4) preconditioned rats subjected to tMCAO (IPC+tMCAO+siCTL), (5) preconditioned rats treated with siRNA against ORAI1 and subjected to tMCAO (IPC+tMCAO+siORAI1), and (6) preconditioned rats treated with siRNA against STIM1 and subjected to tMCAO (IPC+tMCAO+siSTIM1). In the tMCAO group the middle cerebral artery was occluded for 100 minutes, whereas in the ischemic preconditioned groups (IPC), middle cerebral artery was occluded for 30 minutes of tMCAO. When IPC precedeed the tMCAO, 72 hours of reperfusion were allowed between the 2 procedures. For siRNA delivery to the rat brain, animals were placed in a stereotaxic frame (David Kopf Instruments). After a hole was made with a stereotaxic-attached drill, a guide cannula (PlasticOne) was fixed to rat skull with dental cement into left lateral ventricle (0.6 mm posterior to bregma, 1.5 mm lateral to the midline, and 3.2 mm beneath the dura). Each siRNA was injected for 5 minutes at the concentration of 5 µmol/L in a volume of 5 µL, 3 hours before preconditioning, and 3 and 18 hours after preconditioning through an infusion cannula connected to a Hamilton syringe. Vehicle group was injected with an untargeted siRNA. Rectal temperature was maintained at 37±5°C with a thermostatically controlled heating pad; arterial blood gases before and after ischemia were measured by a catheter inserted into the femoral artery (Rapid Laboratory 860, Chiron Diagnostic).
Evaluation of the Infarct Volume
The ischemic volume was evaluated with 2,3,5-triphenyl tetrazolium chloride staining, 24 hours after ischemia.
38,39
Immunocytochemistry
Rats were anesthetized with chloral hydrate (300 mg/kg, intraperitoneally) and perfused transcardially with 4% (w/v) paraformaldehyde. 40 The brains were sectioned coronally at 60 μm. After blocking, sections were incubated with the following primary antibodies: mouse monoclonal anti-NeuN (1:2000; Merk-Millipore, Milan, Italy), polyclonal anti-ORAI1 (No. ACC-062 1:1000; Alomone Lab, Israel), and polyclonal anti-STIM1 (No. ACC-063 1:1000; Alomone Lab). Sections processed for single-labeling light microscopy were incubated with the corresponding biotinylated secondary antibody, and the peroxidase reaction was developed using 3,3-diaminobenzidine/4-HCl. Sections processed for double immunofluorescence analysis were incubated with the corresponding fluorescent-labeled secondary antibodies (Alexa 488/ Alexa 594-conjugated anti-mouse/anti-rabbit IgGs). Controls of the methods in the double immunofluorescence experiments included replacement of the primary antisera with normal serum (1:200). To control for a possible cross-reactivity between IgGs in double immunolabeling experiments, some sections were processed through the same immunocytochemical sequence except that primary antisera were replaced with normal serum or only 1 primary antibody was applied. In addition, all the secondary antibodies were highly preadsorbed to the IgGs of numerous species. Single-labeling light microscopy studies showed ORAI1 and STIM1 distribution on consecutive tissue sections obtained from the same animal groups used in confocal studies. Images were observed using a Zeiss inverted 700 confocal laser scanning microscope (Carl Zeiss, Oberkochen, Germany) and a 63× oil immersion objective.
Evaluation of mRNA and Protein Levels
The following sequences of primers were used for real-time polymerase chain reaction (7500fast; Applied Biosystems) 41 : Orai1 5′-TGGCCGTGCACCTGTTC-3′ and 5′-TTGCTCACAG CCTCGATGTT-3′; Stim1 5′-TCAGCGTGGAGGACCTATGG-3′ and 5′-CACATACGTAATCAGCCACTGTATCA-3′; HPRT 5′-TCCATTC CTATGACTGTAGATTTTATCAG-3′ and 5′-AACTTTTATGTCCC CCGTTGACT-3′.
For protein expression analysis, ice-cold lysis buffer contained 20 mmol/L Tris-HCl (pH 7.5), 10 mmol/L NaF, 1 mmol/L phenylmethylsulfonyl fluoride, 1% NONIDET P-40, 1 mmol/L Na 3 VO 4 , 0.1% aprotinin, 0.7 mg/mL pepstatin, and 1 µg/mL leupeptin. Protein concentration was determined by the 
Proximity Ligation Assay
Cortical neurons plated on glass coverslips were fixed at room temperature in 4% (w/v) paraformaldehyde. Afterward, cells were blocked and incubated overnight at 4°C with monoclonal anti-ORAI1 (No. SAB3500126 1:1000; Sigma-Aldrich, Milan, Italy) and polyclonal anti-STIM1 (No. ACC-063 1:1000; Alomone Lab). Next, cells were visualized with the Red Duolink kit (Sigma-Aldrich).
Statistical Analysis
All data sets are presented as mean±SE. One-way ANOVA and post hoc test with Bonferroni correction or Newman-Keuls correction were performed to compare >2 groups. To compare data sets from 2 groups, parametric unpaired Student t test was performed. Differences were considered statistically significant when the P was <0.05.
Results
STIM1 and ORAI1 Levels in the Ipsilesional Temporoparietal Cortex of Rats Subjected to tMCAO and in Hypoxic Cortical Neurons
The role of ORAI1 and STIM1 in focal ischemia was determined by subjecting adult rats to tMCAO followed by 24 hours of reperfusion. STIM1 and ORAI1 protein expression was significantly reduced in the ipsilesional temporoparietal cortex compared with the corresponding region of sham-operated animals ( Figure 1A) . Furthermore, confocal double labeling immunofluorescence experiments showed that both STIM1 and ORAI1 were abundantly coexpressed in the NeuN-positive cells of the temporoparietal cortex of sham-operated animals ( Figure 1B) . Whereas STIM1 immunosignal was mainly distributed within the soma (Figure 1Ba  through 1Bc) , ORAI1 immunoreactivity was also detected along neuronal processes (Figure 1Bg through IBi). By contrast, STIM1 and ORAI1 immunosignals were concomitantly reduced in the ipsilesional temporoparietal cortex of ischemic animals ( Figure 1Bd through 1Bf and 1Bj-1Bl, respectively) . Furthermore, in the perilesional cortical region of ischemic rats, where ongoing neuronal degeneration can be observed ( Figure I Exposure of cortical neurons to oxygen and glucose deprivation (OGD) for 3 hours dramatically reduced STIM1 and ORAI1 transcripts and proteins (Figure 2Aa and 2Ab and 2Ba through 2Bc). Twenty-one hours after reoxygenation, the transcript levels of STIM1 and ORAI1 but not the proteins returned to pretreatment levels (Figure 2A and 2B) . By contrast, the expression of TRPC1-the main SOCE partner of ORAI1 and STIM1 43 
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STIM1 and ORAI1 Expression in Temporoparietal Cortex of Preconditioned Adult Rats and Preconditioned Cortical Neurons
Seventy-two hours after tolerance induction, single-labeling light microscopy revealed that STIM1 and ORAI1 were upregulated in the ipsilateral temporoparietal cortex of preconditioned rats ( Figure III in the online-only Data Supplement). Furthermore, colocalization experiments revealed that both STIM1 and ORAI1 were intensely upregulated within NeuNpositive neurons ( Figure 3A and 3B). STIM1 immunosignal was intensely detected within the neuronal soma (Figure 3Ad through 3Af), whereas upregulation of ORAI1 was observed not only in the soma but also within a large number of processes (Figure 3Bd through 3Bf) . Interestingly, 72 hours after tolerance induction, STIM1 immunoreactivity also became clearly evident in scattered perineuronal cells resembling glial morphology (see arrows in Figure 3Af ). Moreover, STIM1 and ORAI1 expression peaked in primary cortical neurons exposed to IPC followed by 1 hour of normoxia but returned to the control level at later time points ( Figure 3C and 3D) . The in situ proximity ligation assay showed that there was an increase of contiguity between STIM1 and ORAI1 in preconditioned cortical neurons ( Figure 4A ). More interestingly, this interaction was higher during IPC than in the presence of the sarco/endoplasmic reticulum Ca(2+) ATPase inhibitor thapsigargin ( Figure 4A ). In accordance with these results, IPC enhanced SOCE, whereas siSTIM1 or siORAI1 prevented it (Figure 4Ba and 4Bb) . Moreover, siSTIM1 or siORAI1 prevented ER Ca 2+ accumulation induced by IPC (Figure 4Bc ). Accordingly, I CRAC was significantly increased in neurons exposed to IPC compared with normoxic neurons, whereas siSTIM1 or siORAI1 prevented IPC-induced increase of I CRAC ( Figure 4C ). Finally, in preconditioned neurons, STIM1 antibody clearly depicted a more pronounced immunoreactivity within the neuronal soma (Figure 4Da through 4Dd) and displayed a punctuate staining, which was also associated with a plasma membrane distribution (Figure 4Db through 4Dd) . Moreover, the upregulation of ORAI1 immunosignal was detected along the plasma membrane of both soma and processes of IPC neurons (Figure 4Df and 4Dg ).
Knocking Down STIM1 or ORAI1 Expression on IPC-Induced Neuroprotection
The reduction in STIM1 and ORAI1 protein expression in the ipsilesional cortex of rats subjected to tMCAO was prevented by IPC ( Figure 5A and 5B). Interestingly, IPC determined per se a significant upregulation of both proteins in the same brain region (Figure 5A and 5B). Therefore, rats subjected to IPC plus harmful ischemia were intracerebroventricularly (icv) injected with selective siRNAs against both proteins. Each icv siRNA treatment significantly reverted IPC-induced neuroprotection and IPC-induced improvement of behavioral deficits ( Figure 5C and 5D) .
In vitro, OGD+RX induced a depletion of ER Ca 2+ stores while IPC restored ER Ca 2+ content ( Figure 6A ). Interestingly, siSTIM1 or siORAI1 prevented IPC-dependent restoration of ER Ca 2+ content ( Figure 6A ). Furthermore, oxygen and glucose deprivation+reoxygenation increased GPR78 (BiP) and active caspase-3 protein expression (Figure 6Ba and 6Bb) . However, such effect was prevented by IPC ( Figure 6B ). In contrast, siORAI1 or siSTIM1 significantly counteracted the reduction in GPR78 (Figure 6Ba ) and active caspase-3 induced by IPC (Figure 6Bb ). Moreover, cell death induced by oxygen and glucose deprivation+reoxygenation was prevented by IPC ( Figure 6C and 6D) , whereas IPC-induced neuroprotection was reverted by siORAI1 or siSTIM1 ( Figure 6C and 6D) .
Discussion
The present study has demonstrated for the first time that ORAI1 and STIM1 are involved in the pathophysiology of stroke and in the mechanisms of ischemic tolerance. Indeed ORAI1 and STIM1 level was intensely downregulated in the 
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NeuN-positive cells of the ischemic core of rats subjected to tMCAO. Similarly, their expression and activity were significantly reduced in hypoxic cortical neurons. Another interesting finding of our study is that IPC per se not only triggered the upregulation of ORAI1 and STIM1 expression, activity, and physical interaction but also prevented their downregulation in primary hypoxic cortical neurons and in the ipsilesional cortex of rats subjected to tMCAO. Furthermore, the silencing of ORAI1 or STIM1 significantly counteracted the neuroprotection mediated by IPC in primary hypoxic neurons and in rats subjected to tMCAO.
Furthermore, under low oxygen conditions, IPC (1) increased ORAI1 and STIM1-mediated Ca 2+ refilling into ER, (2) restored ER Ca 2+ homeostasis, and (3) suppressed the upregulation of ER stress markers, that is, GRP78 and caspase-3.
That ORAI1 and STIM1 upregulation occurred after preconditioning in those brain regions that were protected from subsequent ischemic injury further supports the hypothesis that ORAI1 and STIM1 upregulation constitutes a newly identified cell-protective response against stroke. We speculate that neuroprotection mediated by STIM1 and ORAI1 overexpression rely to the restoration of Ca 2+ homeostasis via ER Ca 2+ refilling with subsequent ER stress prevention and reduced cell death. These data are in accordance with our and other previous studies demonstrating (1) the detrimental role played by dysfunctional ER Ca 2+ homeostasis in hypoxic cortical neurons 14 and in the ischemic core 44 and (2) the protective role of Ca 2+ refilling in the ER as an early event occurring in IPC. 8 Several ER proteins are functionally coupled to STIM1/ORAI1 complex. In fact, the sarco/endoplasmic reticulum Ca 2+ ATPase pump colocalizes with STIM1 at the subplasmalemmal region favoring rapid Ca 2+ extrusion after SOCE activation. 45 Furthermore, translocation of IP3Rs to ER-plasma-membrane junctions facilitates STIM/ORAI coupling leading to SOCE activation. 46 Although many ligands of RyRs are able to modulate SOCE through a direct interaction with ORAI, the knowledge on a direct involvement of RyR in STIM1/ORAI1 function still lack. On the contrary, the functional association between RyR1 and TRPC1 channel has been demonstrated. 47 However, how such ER proteins intervening in this complex can take part in SOCE during stroke or IPC remains unknown.
Interestingly, the increase in ORAI1 and STIM1 expression and activity occurring in preconditioned primary cortical neurons was transient and temporally short. On the contrary, the long-lasting neuroprotection observed after induction of IPC suggests that other players may well intervene in the later phases of stroke to maintain ER Ca 2+ refilling, thereby facilitating neuroprotection during subsequent lethal insults. This long-lasting effect could also imply a possible amplification of some signaling cascades mediating ischemic tolerance at the neuronal level. Indeed, silencing of STIM1 and ORAI1 prevented the protective effect of preconditioning after 48 hours. Lastly, because ORAI1 promotes the activation of the protective NFAT (nuclear factor-activated T cells), 48, 49 it is plausible that this plasma membrane channel also contributes to IPC-induced neuroprotection by promoting the activation of this transcription factor. As concerns other mechanisms regulating ORAI1 and STIM1 levels during the ischemic process, the expression of both proteins is modulated by NF-κB 50 -a transcriptional factor mainly involved in determining neuronal fate during stroke 51 and IPC. 52 Furthermore, also Akt plays a regulatory role in ORAI1 expression and SOCE. 53 Interestingly, IPC promotes phosphorylation of Akt at Ser473 regulating both caspase-dependent and caspase-independent cell death. 54 Furthermore, the ubiquitin-like protein ubiquilin-1 colocalizes with the plasma membrane channel facilitating its degradation and thus reducing SOCE. 55 This degradation is efficiently inhibited by bafilomycin-A but not by the proteasome inhibitor MG132, suggesting a lysosomal degradation of ORAI1. 55 Interestingly, ubiquilin-1-dependent ubiquitination 56 and lysosomal-dependent degradation 57 are 2 important processes active during stroke.
Finally, this study demonstrates that ORAI1 and STIM1 are 2 important mediators of preconditioning-mediated tolerance and should, therefore, be considered as new relevant targets in stroke intervention. 
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